SCHEMBL29558149

SCHEMBL29558149

NC(CO)c1ccccc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 1/20 0.45
CNR2 P34972 2/20 0.44
IDO1 P14902 3/20 0.40
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TDO2 P48775 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
P2RX7 Q99572 1/20 0.37
SLC6A4 P31645 1/20 0.37
CACNA2D1 P54289 1/20 0.37
CACNA1B Q00975 1/20 0.37
CACNB1 Q02641 1/20 0.37
CACNA1C Q13936 1/20 0.37
MC4R P32245 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10216843 1.00 ACP3 (0.45) ACP3CNR2IDO1ALDH1A1POLB
Hydrochloric Acid SCHEMBL382176 0.98 ACP3 (0.44) ACP3CNR2IDO1ALDH1A1POLB
SCHEMBL19265315 0.85 ACP3 (0.42) ACP3CNR2IDO1ALDH1A1POLB
SCHEMBL10216941 0.85 ACP3 (0.42) ACP3CNR2IDO1ALDH1A1POLB
SCHEMBL17818994 0.84 P2RX7 (0.54) ACP3CNR2IDO1TDO2P2RX7
Hydrochloric Acid SCHEMBL409850 0.83 ACP3 (0.41) ACP3CNR2IDO1ALDH1A1POLB
SCHEMBL10591850 0.82 ALDH1A1 (0.42) ALDH1A1POLBTDP1GAAGRIN2D
SCHEMBL11662073 0.82 HTR2C (0.42) ACP3CNR2IDO1ALDH1A1POLB
SCHEMBL8396680 0.82 ACP3 (0.46) ACP3CNR2IDO1ALDH1A1POLB
SCHEMBL1729214 0.80 MC4R (0.42) ACP3CNR2IDO1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057765-A 3-aryl-4-amido-bicyclo [4,5,0] hydroxamic acids as HDAC inhibitors 瓦洛健康股份有限公司 2022-02-18 CN disclosed